Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64

United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

15 insiders · 24 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John G Houston

Director

—

$466.15K (3)

−$466.15K

1,122,183

1.72%

$9.16M

+8.2%

Briggs Morrison

Director

$268.07K (1)

—

+$268.07K

111,548

0.1706%

$910.12K

+271.9%

Noah Berkowitz

Chief Medical Officer

—

$249.41K (3)

−$249.41K

191,395

0.2927%

$1.56M

+201.6%

Randy Teel

President and CEO

—

$226.48K (5)

−$226.48K

285,009

0.4359%

$2.33M

+80.1%

Andrew Saik

Chief Financial Officer

—

$218.21K (3)

−$218.21K

187,432

0.2867%

$1.53M

+205.2%

Angela M Cacace

Chief Scientific Officer

—

$214.01K (5)

−$214.01K

180,390

0.2759%

$1.47M

+234.5%

David K Loomis

VP, Chief Accounting Officer

—

$46.90K (4)

−$46.90K

40,193

0.0615%

$327.93K

+262.7%

Ian Taylor

President, R&D

—

—

—

159,121

0.2434%

$1.30M

+7.9%

Edward Moore Kennedy Jr.

Director

—

—

—

54,957

0.0840%

$448.39K

+134.8%

Leslie Norwalk V

Director

—

—

—

41,572

0.0636%

$339.19K

+314.9%

Everett Cunningham

Director

—

—

—

41,572

0.0636%

$339.19K

+314.9%

Alsup Laurie Smaldone

Director

—

—

—

41,572

0.0636%

$339.19K

+314.9%

Linda Bain

Director

—

—

—

41,572

0.0636%

$339.19K

+314.9%

Sunil Agarwal

Director

—

—

—

30,166

0.0461%

$246.12K

+113.3%

John D Young

Director

—

—

—

26,045

0.0398%

$212.50K

+159.9%